FDA NDC Directory · JSON-LD · Markdown

PROCYSBI

NDC 75987-145 · HUMAN PRESCRIPTION DRUG · GRANULE, DELAYED RELEASE

Generic nameCysteamine bitartrate
Labeler / ManufacturerHorizon Therapeutics USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA213491
Dosage form / routeGRANULE, DELAYED RELEASE · ORAL
Active ingredientsCYSTEAMINE BITARTRATE (300 mg/1)
Marketing started20200214
Package count2

External sources

Source: openFDA. Public-domain (CC0).